Trials / Completed
CompletedNCT01925547
Micellar Curcumin and Metabolic Syndrome Biomarkers
Effect of Micellar Curcumin on Inflammation and Lipid Metabolism Markers
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- University of Hohenheim · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the effect of micellar curcumin on inflammation and lipid metabolism markers in subjects at risk for the metabolic syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Micellar curcumin | 80 mg micellar curcumin (oral) three times a day for six weeks |
| DIETARY_SUPPLEMENT | Placebo | Only the excipients (without curcumin) used to prepare the curcumin micelles are given as placebo. |
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2014-03-01
- Completion
- 2014-10-01
- First posted
- 2013-08-19
- Last updated
- 2016-10-25
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01925547. Inclusion in this directory is not an endorsement.